Antimicrobial Resistance (AMR) - 28 September 2017

RSSrss icon

AMR is a major global public health threat, which risks us going back to a ‘pre-antibiotic era’, where patients could die from simple bacterial infections and life-saving treatments can no longer be performed safely. Across the EU, 25 000 people die each year from drug resistant infections (WHO). Worldwide, this number will increase to 10 million by 2050, according to the UK AMR Review (2016). Not only will this impact patient safety and recovery, but AMR also puts a heavy burden on the economy due to loss of income and productivity, as well as informal care requirements. In Europe, the annual extra healthcare costs and productivity losses due to multidrug-resistant bacteria amount to 1.5 billion euros (European Commission, 2016).

The role of medtech in fighting resistance … read more: